From reuters.com
Feb 4 (Reuters) – Medical products maker Tissue Regenix Group said on Tuesday its U.S. manufacturing plant had resumed operations following last week’s cyber attack on its computer network.
The incident is expected to hit order processing for a “very short-term”, London-listed Tissue Regenix said, adding that delayed orders would be shipped over the coming weeks.